A Tecfidera Comeback? Investors Await More On Patent Plans From Biogen

 
• By Jessica Merrill

Biogen has been granted new US patents for Tecfidera after generics already launched. It's unclear how Biogen will proceed but management could shed more light on the matter during the first quarter call.

A microphone falling onto a stage floor.
Biogen could be setting the stage for a Tecfidera comeback • Source: Alamy (Victor Lucas / Alamy Stock Photo/Alamy Stock Photo)

More from Legal & IP

More from Business